Authors:
Doze, P
Elsinga, PH
de Vries, EFJ
Van Waarde, A
Vaalburg, W
Citation: P. Doze et al., Mutagenic activity of a fluorinated analog of the beta-adrenoceptor ligandcarazolol in the Ames test, NUCL MED BI, 27(3), 2000, pp. 315-319
Authors:
Visser, TJ
van der Wouden, EA
van Waarde, A
Doze, P
Elsinga, PH
Vaalburg, W
Citation: Tj. Visser et al., Synthesis and biodistribution of [C-11]procaterol, a beta(2)-adrenoceptor agonist for positron emission tomography, APPL RAD IS, 52(4), 2000, pp. 857-863
Authors:
Doze, P
Van Waarde, A
Elsinga, PH
Hendrikse, NH
Vaalburg, W
Citation: P. Doze et al., Enhanced cerebral uptake of receptor ligands by modulation of P-glycoprotein function in the blood-brain barrier, SYNAPSE, 36(1), 2000, pp. 66-74
Authors:
Visser, TJ
van Waarde, A
Doze, P
Wegman, T
Vaalburg, W
Citation: Tj. Visser et al., Preclinical testing of N-[C-11]-methyl-piperidin-4-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate, a novel radioligand for detection of cerebral muscarinic receptors using PET, SYNAPSE, 35(1), 2000, pp. 62-67
Authors:
Hospers, GAP
Calogero, A
van Waarde, A
Doze, P
Vaalburg, W
Mulder, NH
de Vries, EFJ
Citation: Gap. Hospers et al., Monitoring of herpes simplex virus thymidine kinase enzyme activity using positron emission tomography, CANCER RES, 60(6), 2000, pp. 1488-1491
Authors:
Visser, TJ
van Waarde, A
Doze, P
Elsinga, PH
van der Mark, TW
Kraan, J
Ensing, K
Vaalburg, W
Citation: Tj. Visser et al., Characterisation of beta(2)-adrenoceptors, using the agonist [C-11]formoterol and positron emission tomography, EUR J PHARM, 361(1), 1998, pp. 35-41